r e S O u r C e ALS is a devastating and fatal neurodegenerative disease that affects predominantly upper and lower motor neurons, although there is evidence suggesting that it is a multisystem disease involving other brain regions 1 . Approximately 90% of ALS cases are sporadic, with the remaining 10% being inherited familial ALS (fALS). Mutations in several genes are known to cause fALS and a small proportion of seemingly sporadic cases. This underscores the etiological diversity of ALS, despite clinical and neuropathological similarities among familial and sporadic forms, and calls attention to the need for treatments for specific forms of ALS. Thus the discovery of a G 4 C 2 repeat expansion in C9orf72 as the most common known cause of ALS 2,3 offers an exciting opportunity to uncover aberrant events initiated by this genetic abnormality.
r e S O u r C e
To identify c9ALS-specific transcriptome changes, we also analyzed RNA from sALS subjects (N = 10) with no mutations in the most common ALS-associated genes, as well as from subjects without neurological disease (controls; N = 8-9). Age at onset of motor neuron disease symptoms did not differ significantly between subjects with c9ALS (median, 49.6 years (25th and 75th percentiles: 46.0 and 55.1)) and those with sALS (median, 58.9 years (25th and 75th percentiles: 47.9 and 64.7)) (P = 0.118). Disease duration also did not differ significantly between individuals with c9ALS (median, 30.4 months (25th and 75th percentiles: 16.9, 49.0)) and those with sALS (median, 38.5 months (25th and 75th percentiles: 22.2, 55.2)) (P = 0.769). Motor neuron disease was noted to affect upper and lower motor neurons with observed depopulation of Betz cells in the motor cortex of both c9ALS and sALS subjects. TDP-43 pathology was found in the motor cortex, hypoglossal nucleus and anterior horn cells, with glial cytoplasmic inclusions and skein-like neuronal cytoplasmic inclusions characteristic of ALS. Alzheimer's-type pathology did not differ among c9ALS, sALS and control subjects (all Braak tangle stage I (0, II)) (P = 0.964). Clinical and neuropathological information can be found in Supplementary Table 1 . Paired-end RNA-Seq was done with the Illumina HiSeq 2000 platform, and the sequencing reads were aligned to the hg19 human genome (Online Methods). The average number of reads was ~83 million (91.5 million for cerebellum and 73.6 million for frontal cortex), with approximately 72% of total reads mapping to the human transcriptome (72.4% for cerebellum and 71.4% for frontal cortex). As described below, we used computational analyses to evaluate differentially expressed (DE) genes, AS and APA in c9ALS and sALS transcriptomes.
Gene expression is differentially misregulated in ALS
To identify DE genes in c9ALS and sALS in comparison with controls (P < 0.05), we carried out EdgeR analyses on the aligned RNA-Seq data. The MA plots shown in Figure 1a -d highlight genes that were up-or downregulated by at least twofold (|log 2 fold change (FC)| ≥ 1) in ALS subjects. Individuals with c9ALS showed a greater number of upregulated genes than of downregulated ones, with far more DE genes in the cerebellum than in the frontal cortex (Fig. 1a,b ). In contrast, the numbers of up-and downregulated genes in sALS subjects were similar, and no marked differences were observed between the cerebellum and frontal cortex (Fig. 1c,d ). When we examined only genes DE by at least fourfold (|log 2 FC| ≥ 2), we identified 361 genes in the cerebellum of c9ALS subjects, compared with only 136 in sALS subjects (Fig. 1e) . In the frontal cortex, 241 DE genes were found in c9ALS subjects, compared with 136 in sALS subjects (Fig. 1f) .
Fifty-seven genes in cerebellum and 32 genes in frontal cortex were abnormally expressed in both c9ALS and sALS subjects. These similarities are perhaps indicative of common molecular pathways.
Indeed, gene ontology (GO) analyses showed a predominance of genes involved in inflammatory and defense responses in both cerebellum and frontal cortex in c9ALS and sALS subjects (Supplementary  Tables 2 and 3) . Nevertheless, the fact that the number of misregulated genes in c9ALS was approximately double that in sALS suggests differences between these two forms of ALS. Of note, the unfolded protein response (UPR) was a GO pathway identified from genes differentially upregulated in c9ALS but not in sALS ( Supplementary  Tables 4 and 5) . The divergence between c9ALS and sALS or controls was corroborated by findings from hierarchical clustering (Fig. 1g,h ) and principal-component analyses (Supplementary Fig. 1 ) of DE genes in c9ALS cerebellum or frontal cortex. Indeed, c9ALS samples clustered together and were separated not only from controls but also from sALS samples, an effect independent of clinical features ( Supplementary Figs. 2 and 3) .
To evaluate differences in expression between c9ALS or sALS and controls at a systems level, we carried out weighted gene-coexpression correlation network analyses (WGCNAs). Several significant modules were identified, and the GO annotation of a given module determined the functional pathways of genes in that module (Online Methods). In c9ALS, the top module identified in cerebellum was enriched in genes involved in neuron development, protein localization and transcription ( Table 1 and Fig. 2a) , whereas the top module identified in npg r e S O u r C e the frontal cortex was enriched in UPR-related genes ( Table 1 and Fig. 2b) . Of note, genes involved in the UPR pathway were among the top DE genes in both cerebellum and frontal cortex in c9ALS subjects as determined by EdgeR analyses, as mentioned above, and validated by quantitative real-time PCR (qRT-PCR) ( Supplementary  Fig. 4 ). In sALS, the top modules identified included genes involved in calcium transport and synaptic transmission in cerebellum and in oxidative phosphorylation in frontal cortex (Supplementary Table 6 ). These studies revealed marked differences in gene-expression patterns between c9ALS and sALS subjects, with substantially more changes observed in individuals with c9ALS, especially in the cerebellum.
Extensive misregulation of AS in ALS brain
To evaluate AS changes in ALS, we used OLego software 30 to align RNA-Seq reads to the hg19 genome assembly and splice junctions. The total number of AS events (false discovery rate (FDR) < 0.05) was more than three times higher in c9ALS subjects than in sALS subjects in both cerebellum (8, 224 in c9ALS versus 2,229 in sALS) and frontal cortex (920 in c9ALS versus 282 in sALS) ( Fig. 3a and Supplementary Tables 7  and 8) . Also, the number of AS events was approximately eight to nine times higher in the cerebellum than in the frontal cortex in c9ALS and sALS samples (Fig. 3a) . Although 1,172 and 106 of the AS events that occurred in the cerebellum and frontal cortex, respectively, were shared between c9ALS and sALS subjects, they represented a relatively small percentage (~11%-15%) of the total AS changes seen in c9ALS subjects.
Among the different types of AS changes noted in ALS, cassette exon (CE) events were the most common, and intron-retention events represented a significant proportion of total changes (FDR < 0.05; Fig. 3b) . A total of 918 intron-retention events occurred in c9ALS cerebellum, whereas 286 were found in c9ALS frontal cortex. In sALS subjects, there were 378 alternative intron-retention events in the cerebellum but only 7 in the frontal cortex ( Fig. 3b and Supplementary Fig. 5 ). In c9ALS subjects, approximately 12 times more AS CE events (FDR < 0.05) were found in the cerebellum (4,419) than in the frontal cortex (369) ( Fig. 3b and Fig. 4a,b) . In sALS subjects, there were 949 AS CE events in the cerebellum, more than four times the number of events in the frontal cortex (203) ( Fig. 3b and Fig. 4a,b) .
The majority of CE events in c9ALS were the result of exon skipping, whereas similar proportions of CE exclusions and inclusions WGCNA modules were done with data from c9ALS cerebellum and frontal cortex (versus sALS and controls; P < 0.05). All significant modules are shown. The most notable GO terms and their enrichment P values are included for each module. Note that MEpink is shown in blue in Figure 2a , and MEsalmon is shown in red in Figure 2b . Network diagrams for these two modules are shown on the right, with node color darkness correlating with the number of connections (degree). Note that eight genes in the top coexpression module in c9ALS frontal cortex were differentially expressed (those in red font and BAG3). The increase in expression for seven of the genes (those in red font) was validated by qRT-PCR in cerebellum and frontal cortex tissues ( Supplementary Fig. 4) . c9ALS, N = 8; sALS, N = 10; controls, N = 8 cerebellum, N = 9 frontal cortex. npg r e S O u r C e were observed in sALS (Fig. 4c-f) . Similarly, hierarchical clustering of differentially spliced CEs in c9ALS cerebellum and frontal cortex not only demonstrated clear differences between c9ALS and sALS subjects, as well as between ALS subjects and controls, but also illustrated the abundance of AS CEs in c9ALS subjects independent of clinical features (Supplementary Figs. 6 and 7) .
Systematic qRT-PCR validation of some of the top AS CEs in c9ALS cerebellum (Fig. 5a, Supplementary Fig. 8 and Supplementary Table 9 ) and frontal cortex (Supplementary Fig. 9 ) confirmed the occurrence of CE skipping events, some of which were also observed in sALS, including those in known neurodegenerative disease-related genes. For instance, exon 21 (chr12:111,902,466-111,902,519) was likely to be spliced out of ATXN2 transcripts, and exon 10 (chr17:44,087,676-44,087,768) tended to be spliced out of microtubule-associated protein tau (MAPT) transcripts (Fig. 5a and Supplementary Fig. 9 ). ATXN2 lacking exon 21 corresponds to ATXN2 transcript variant type IV, which is found in neuronal and non-neuronal tissues 31 , whereas AS of exon 10 in MAPT disrupts the ratio of tau proteins containing three or four microtubule-binding domains 32 . Other validated AS CEs included α-actinin 1 (ACTN1) smooth muscle exon (chr14:69,345,175-69,345,240), which dictates calcium sensitivity 33 ; poly(ADP-ribosyl) polymerase family member 6 (PARP6) exon 17 (chr15:72,543,186-72,543,295), which is part of the catalytic domain and may affect PARP6's role in cell cycle regulation 34 ; hypoxia inducible factor 1-α subunit (HIF1A) exon 14 (chr14:62,212,409-62,212,535), an AS isoform of a transcriptional regulator for hypoxia response 35 ; and RNA binding motif protein 39 (RBM39) (chr20:34,317,384-34,317,449), encoding a protein involved in AS and transcription ( Fig. 5a and Supplementary Figs. 8 and 9) . We further demonstrated that these exon-skipping events were ALS specific and not a consequence of neurodegeneration, as they were not observed in postmortem brain of subjects with progressive supranuclear palsy (Fig. 5b) .
As ALS subjects present motor neuron involvement, we examined whether the splicing events we identified also occur in c9ALS motor cortex. Among a total of 14 exon-skipping events validated in cerebellum and frontal cortex of c9ALS subjects, 6 events were also observed in motor cortex in the same subjects (Supplementary Fig. 10) , further supporting the importance of these transcript changes to disease.
To assess whether specific RBPs may regulate AS of CEs (discussed above), we identified motifs enriched in AS CEs and flanking intronic regions and cross-referenced them against an RBP-motif database 36 (http://rbpdb.ccbr.utoronto.ca). Multiple references to hnRNPH were found for c9ALS and sALS (Supplementary Fig. 11 ). This finding is congruent with a previous report of hnRNPH sequestration by foci in c9ALS 19 , which is expected to influence hnRNPH function, npg r e S O u r C e and also suggests a potential role for hnRNPH in sALS. Other binding motifs enriched in the cerebellum included those recognized by serine/arginine-rich splicing factor 1 (SRSF1). The binding motif recognized by matrin 3 (MATR3) was enriched in sALS AS CEs, which is notable because mutations in MATR3 are causative for ALS 37 .
To identify cellular pathways affected by CE mis-splicing in c9ALS and sALS, we conducted gene-association network analyses using the STRING web tool along with the Cytoscape network analyzer (Online Methods). No significant networks were generated for frontal cortex tissues, probably because of the relatively low number of AS events in this brain region; however, several misregulated networks were identified in the cerebellum. GO network annotation predicted RNA processing as the most altered pathway in c9ALS cerebellum ( Fig. 5c and  Supplementary Fig. 12 ). Cytoskeleton and cellular trafficking pathways were largely altered in sALS cerebellum (Supplementary Fig. 13 ).
Widespread APA events in ALS APA events can arise when more than one functional polyadenylation site (PAS) is present in the 3′ UTR of an mRNA. We examined APA events in ALS with DaPars software 38 . Relative to controls, the total number of PAS shifts (FDR < 0.05, |∆PDUI| ≥ 0.2, |dPDUI| ≥ 0.2, where PDUI is the differential PAS usage index, |∆PDUI| is the absolute change in PDUI, or the ratio of distal and proximal PAS use, for each gene in one condition, and |dPDUI| is the differential PDUI, or the difference in PAS use between control and disease) in the cerebellum was higher in c9ALS subjects (1,437) than in sALS subjects (716), with c9ALS subjects showing increased use of proximal PASs (1,057) compared with their use of distal PASs (380), whereas sALS subjects showed similar distributions of proximal (369) and distal (347) PAS use (Fig. 6a,b) . GO analyses of transcripts with PAS shifts in cerebellum revealed top pathways of RNA processing in c9ALS (Supplementary Table 10 ) and response to oxidative stress in sALS (Supplementary Table 11) . Figure 6c,d shows examples of proximal PAS shifts in c9ALS and sALS cerebellum, with miRNA binding sites on the 3′ UTRs depicted. Note that in the event that a more proximal PAS is used, miRNA binding to the 3′ UTR will be circumvented. In contrast to the cerebellum, the number of APA events in the frontal cortex was lower in c9ALS subjects (968) than in sALS subjects (1, 266) , with c9ALS subjects displaying similar proportions of proximal (443) and distal (525) PAS shifts, whereas sALS Supplementary Fig. 8 ). Images are representative of three technical qRT-PCR replicates performed for each AS event in c9ALS (N = 9) and sALS (N = 10) cerebellum compared to controls (N = 9). (b) qRT-PCR data for the same differentially misregulated CEs in c9ALS (N = 9) and sALS (N = 10) cerebellum shown in a compared with a disease control group (PSP, progressive supranuclear palsy; N = 13). Relative mRNA levels shown in all bar graphs were normalized to the endogenous control, RPLP0, and to respective controls (mean value set to 1). The full list of primers used in this study can be found in Supplementary Table 9 . Statistical differences were calculated by one-way analysis of variance with Bonferroni post-hoc test (*P < 0.05, **P < 0.01, ***P < 0.005, # P < 0.001). Exact P values can be found in Supplementary Figure 8 . (c) Gene-association network of the top most significant misregulated CE events in c9ALS cerebellum (FDR < 0.05, |dI| ≥ 0.1). c9ALS, N = 8; sALS, N = 10; controls, N = 8. Genes are represented by nodes of different colors, with colors corresponding to degree as defined in the key. Node size denotes neighborhood connectivity: nodes are bigger if they are connected to other nodes with higher connectivity. Edges are colored according to edge between-ness to indicate proximity to other nodes, with low between-ness (closer proximity) meaning greater influence on other nodes (colors defined in key). GO annotations for different interconnected cellular pathways are indicated. A more complete representation showing all genes for each node can be found in Supplementary Figure 11 .
npg r e S O u r C e subjects showed increased use of distal (776) compared to proximal (490) PASs (Fig. 6e,f) . Interestingly, the main GO pathways of transcripts characterized by alternative PAS use in both c9ALS and sALS frontal cortex present roles in transcription ( Supplementary  Tables 10 and 11 ).
DISCUSSION
Misregulated RNA processing and metabolism are recurrent themes in neurological disorders, but their involvement in c9ALS is not clearly established. The present study reports widespread transcriptome changes in individuals with ALS carrying a C9orf72 repeat expansion, as well as in those with sALS. Our analyses showed major misregulated RNA-processing events in ALS, several of which affected genes previously associated with ALS, such as ATXN2 and FUS [24] [25] [26] 39 . Overall, the c9ALS transcriptome was affected to a greater degree than that of sALS, with little overlap. This limited overlap may result from the presence of pathological features unique to c9ALS in the frontal cortex and cerebellum, as well as heterogeneity among sALS cases (for example, mutation in an unknown gene), which may mask transcriptional changes that occur in subsets of cases. Nonetheless, several aberrant transcriptome changes were shared between people with c9ALS and sALS, perhaps indicating common pathological mechanisms or pathways altered as an indirect consequence of the disease process. Although TDP-43 inclusions were present in both c9ALS and sALS, the frontal cortex and cerebellum were relatively spared of this pathology, rendering a contribution of misregulated TDP-43 to common changes unlikely. The pronounced number of transcriptional changes in individuals with c9ALS is presumably due to the presence of RNA foci and DPR protein pathology as a consequence of r(G 4 C 2 ) exp and r(G 2 C 4 ) exp accumulation. For example, several RBPs (for example, hnRNPH) interact with DPR proteins 12, 15, 40 or bind RNA foci 19 , and these associations may influence RNA processing and account for many of the RNA defects in c9ALS. With this in mind, it is of interest that reverseengineering analysis of over-represented RBP motifs in sequences surrounding misregulated AS CEs in c9ALS cerebellum and frontal cortex showed enrichment for binding motifs for hnRNPH.
Differences in RNA processing in c9ALS could be caused by other factors. For example, it was recently shown that DPR proteins cause endoplasmic reticulum (ER) stress in primary neurons 11 . UPR genes, which are activated by ER stress, were among the top DE genes in c9ALS cerebellum and frontal cortex. Notably, the UPR pathway was not a top GO category in sALS. Although pathological TDP-43, like DPR proteins, may cause dysfunction of the UPR, little TDP-43 pathology is observed in postmortem frontal cortex and cerebellum from individuals with ALS. Several studies have also shown that some DPR proteins cause nucleolar stress, as well as impair RNA biogenesis and RNA granule formation, which suggests that these DPR proteins lead to global perturbation in RNA processing 9, 12, 14, 15 . Despite these impressive advances, it remains unclear which neuropathological features of c9ALS contribute to disease pathogenesis and/or correlate with the observed transcriptome defects.
In addition to differences in gene-expression profiles between people with c9ALS and those with sALS, differences in AS and APA events further establish the distinction between c9ALS and sALS. Although defects in RNA processing and metabolism are observed in both c9ALS and sALS brains, our studies highlighted major differences in functional pathways that may be affected in c9ALS and sALS. Indeed, in addition to the UPR, the intracellular protein transport and localization pathway is affected in c9ALS. Some of the genes involved in this pathway encode proteins involved in transport or docking of synaptic vesicles (e.g., syntaxins) and in nuclear transport (e.g., nucleoporins and exportins), which is particularly intriguing given the increasing interest in impaired nuclear transport in c9ALS. In contrast, the majority of pathways that may be affected in sALS involve cytoskeleton organization, defense response and synaptic transmission.
Approximately ~70% of human genes undergo APA in a tissuespecific manner 41 . As the 3′ UTRs of genes contain binding sites for several RBPs and miRNAs, APA has important roles in regulating gene expression, RNA localization and RNA translation. Thus, the presence of distinct PAS shifts in the brains of both c9ALS and sALS subjects is of particular interest. Indeed, widespread PAS shifts are associated with several human diseases 42, 43 , and this study now adds ALS to the list.
Unexpectedly, more robust transcriptome changes were found in the cerebellum than in the frontal cortex. Although the role of the cerebellum in coordination and motor control is well documented, its involvement in ALS has been largely overlooked. Cerebellar atrophy is observed in ALS and behavioral variant frontotemporal dementia (bvFTD), which is believed to be part of the same spectrum of npg r e S O u r C e neurodegenerative diseases as ALS [44] [45] [46] [47] . In fact, differences between ALS and bvFTD syndromes may depend partly on the cerebellar subregions affected, with ALS cases showing atrophy in the inferior cerebellum and vermis, which is associated with motor dysfunction, and bvFTD cases showing widespread atrophy predominantly in the superior cerebellum 46 . Furthermore, studies prompted by the discovery of the C9orf72 repeat expansion in c9ALS, coupled with the fact that subjects with this repeat expansion show marked cerebellar pathology, have shown that cerebellar atrophy is also common to these patients [48] [49] [50] . Overall, the data presented herein provide evidence that disruption of normal RNA processing is part of the pathological signature of c9ALS and sALS. Additionally, these findings show that c9ALS and sALS have distinct transcriptome profiles, and they call attention to the potential contribution of the cerebellum to the disease.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. All RNA-Seq data for each individual RNA sample from cerebellum or frontal cortex tissue are available at the NCBI Gene Expression Omnibus under accession number GSE67196. 
